BYSL

Bystin · Q13895 · BYSL on Sugi Atlas →

0 patent compounds predicted against BYSL, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to BYSL by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial PHASE4COMPLETED
OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER PHASE3UNKNOWN
Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL) PHASE3RECRUITING
Omega-3 Oil Use in COVID-19 Patients in Qatar PHASE3UNKNOWN
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study PHASE2UNKNOWN
Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis PHASE1UNKNOWN
Assessment of Potential Biomarkers in Women With Symptoms of Overactive Bladder and Pelvic Organ Prolapse nanUNKNOWN
Value of Inguinal Exploration for Impalpable Testes nanUNKNOWN
Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings nanUNKNOWN
Influence of Sarcopenia on the Course of the Diseases nanRECRUITING
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study nanENROLLING_BY_INVITATION
BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19 nanUNKNOWN
A Study of Population and Sex-specific Troponin Cutoffs for Ruling Out Acute Myocardial Infarction nanCOMPLETED
Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD nanNOT_YET_RECRUITING
SIBlos EXtension Study (SIBEX) nanCOMPLETED
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF nanACTIVE_NOT_RECRUITING
Optimization Study of Cardiac Risk Patients With Hip Fracture nanUNKNOWN
Minor Troponin Elevations in Patients With Atrial Fibrillation nanCOMPLETED
Arterial Composition and Cardiovascular Outcome in DIabeteS nanUNKNOWN
Urinary NGF as A Biomarker for Acute Bacterial Cystitis nanCOMPLETED
IGF and Other Neurotrophic Factors in Patients With Dementia nanCOMPLETED
NGF, TrKA,p75NTR in Men With ED and Diabetes With or Without MS nanUNKNOWN
A Pilot Study of Biomarkers in Obstructive Sleep Apnea nanCOMPLETED
Neurological Prognostication of Patients in Therapeutic Hypothermia After Cardiac Arrest nanCOMPLETED
A Health Economic Evaluation of Using N-Terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) in Acute Heart Failure nanCOMPLETED
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide (Chemiluminescence Method) nanCOMPLETED
Brain-Induced Neurotrophic Factor Levels in Patients Undergoing Coronary Artery Bypass Surgery nanCOMPLETED
Association of Urine BDNF and NGF With Lower Urinary System Parameters nanRECRUITING
The Usefulness of Growth Differentiation Factor 15 (GDF-15) for Risk Stratification in Cardiac Surgery nanCOMPLETED
Biomarkers and Outcome 1 and 10-15 Years After Severe Traumatic Brain Injury nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a BYSL binder may also engage these)

ProteinNameSimilarity
Q80WL2 1.000 Q80WL2 →
O54825 1.000 O54825 →
Q5E9N0 1.000 Q5E9N0 →
Q20932 0.998 Q20932 →
A9UNU6 0.996 A9UNU6 →
P51406 0.992 P51406 →
Q8RWS4 0.992 Q8RWS4 →
Q9UPV7 0.992 Q9UPV7 →
A7S7F2 0.992 A7S7F2 →
P54634 0.992 P54634 →
Q9W1R5 0.991 Q9W1R5 →
Q9VR99 0.991 Q9VR99 →
Q9CQA8 0.991 Q9CQA8 →
Q54IS0 0.991 Q54IS0 →
Q8K305 0.990 Q8K305 →
Q6IV56 0.990 Q6IV56 →
P0C7L7 0.990 P0C7L7 →
O08788 0.990 O08788 →
BPTF Nucleosome-remodeling factor subunit BPTF 0.990 landscape →
F5HB62 0.990 F5HB62 →
Q4V8Z3 0.990 Q4V8Z3 →
Q18892 0.990 Q18892 →
B6KG46 0.989 B6KG46 →
P0CK62 0.989 P0CK62 →
Q291E4 0.989 Q291E4 →
RTRAF RNA transcription, translation and transport factor protein 0.989 landscape →
Q66624 0.989 Q66624 →
Q9QZX9 0.989 Q9QZX9 →
A2Y4R8 0.989 A2Y4R8 →
Q60DW3 0.989 Q60DW3 →